TY - JOUR
T1 - Prostate cancer epigenetics
T2 - From basic mechanisms to clinical implications
AU - Yegnasubramanian, Srinivasan
AU - De Marzo, Angelo M.
AU - Nelson, William G.
N1 - Funding Information:
This work was supported by Prostate Cancer Foundation Challenge Awards (to S.Y. and W.G.N.), National Institutes of Health (NIH)/ National Cancer Institute (NCI) Grants U01CA196390, P30CA006973, P50CA058236, and R01CA070196. Conflicts of interest: S.Y., W.G.N., and A.M.D.M. are paid consultants to Cepheid LLC, with whom they are developing epigenetic tests for prostate cancer. S.Y. has received sponsored research support from Cepheid for development and testing of prostate cancer epigenetic biomarkers. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict of interest policies.
Publisher Copyright:
© 2019 Cold Spring Harbor Laboratory Press; all rights reserved.
PY - 2019/4
Y1 - 2019/4
N2 - A level of epigenetic programming, encoded by complex sets of chemical marks onDNAand histones, and by context-specific DNA, RNA, protein interactions, that all regulate the structure, organization, and function of the genome, is critical to establish both normal and neoplastic cell identities and functions. This structure–function relationship of the genome encoded by the epigenetic programming can be thought of as an epigenetic cityscape that is built on the underlying genetic landscape. Alterations in the epigenetic cityscape of prostate cancer cells compared with normal prostate tissues have a complex interplay with genetic alterations to drive prostate cancer initiation and progression. Indeed, mutations in genes encoding epigenetic enzymes are often observed in human cancers including prostate cancer. Interestingly, alterations in the prostate cancer epigenetic cityscape can be highly recurrent, a facet that can be exploited for development of biomarkers and potentially as therapeutic targets.
AB - A level of epigenetic programming, encoded by complex sets of chemical marks onDNAand histones, and by context-specific DNA, RNA, protein interactions, that all regulate the structure, organization, and function of the genome, is critical to establish both normal and neoplastic cell identities and functions. This structure–function relationship of the genome encoded by the epigenetic programming can be thought of as an epigenetic cityscape that is built on the underlying genetic landscape. Alterations in the epigenetic cityscape of prostate cancer cells compared with normal prostate tissues have a complex interplay with genetic alterations to drive prostate cancer initiation and progression. Indeed, mutations in genes encoding epigenetic enzymes are often observed in human cancers including prostate cancer. Interestingly, alterations in the prostate cancer epigenetic cityscape can be highly recurrent, a facet that can be exploited for development of biomarkers and potentially as therapeutic targets.
UR - http://www.scopus.com/inward/record.url?scp=85064197702&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064197702&partnerID=8YFLogxK
U2 - 10.1101/cshperspect.a030445
DO - 10.1101/cshperspect.a030445
M3 - Article
C2 - 29959132
AN - SCOPUS:85064197702
SN - 2157-1422
VL - 9
JO - Cold Spring Harbor Perspectives in Medicine
JF - Cold Spring Harbor Perspectives in Medicine
IS - 4
M1 - a030445
ER -